NCT04181541 is a NA clinical trial of Provider type: Physicians in Induced Abortion, sponsored by Ipas.

Who is sponsoring NCT04181541?

NCT04181541 is sponsored by Ipas.

What drugs are being tested in NCT04181541?

Interventions in NCT04181541: Provider type: Physicians, Provider type: Midlevel Providers.

What condition does NCT04181541 study?

NCT04181541 studies Induced Abortion, Second Trimester Abortion, Medical Abortion, Health Personnel.

Is NCT04181541 still recruiting?

NCT04181541 is currently completed. Last updated 20 September 2021.

Last reviewed 2021-09-20 · How we verify

NCT04181541

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Midlevel Versus Physician-provided Medical Abortion in the Second Trimester

Completed NA Last updated 20 September 2021

What this trial tests

NA trial testing Provider type: Physicians in Induced Abortion in 245 participants. Completed in 3 March 2021.

Timeline

17 February 2020

Primary endpoint
24 February 2021

3 March 2021

Quick facts

Lead sponsor	Ipas
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	245
Start date	17 February 2020
Primary completion	24 February 2021
Estimated completion	3 March 2021
Sites	1 location across Ethiopia

Drugs / interventions tested

Provider type: Physicians
Provider type: Midlevel Providers

Conditions studied

Induced Abortion — all drugs for Induced Abortion →
Second Trimester Abortion — all drugs for Second Trimester Abortion →
Medical Abortion — all drugs for Medical Abortion →
Health Personnel — all drugs for Health Personnel →

Sponsor

Ipas — full company profile →

Who can join

16 and older, female only, with Induced Abortion or Second Trimester Abortion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to determine the safety and effectiveness of second trimester medical abortion when provided by nurse midwives compared with physicians. The study sample will be obtained from Michu Clinic, affiliated with St Paul's hospital, in Addis Ababa.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ipas trials

Trials by the same sponsor.

NCT04290832 — Developing and Testing Interventions to Address Conscientious Objection to Abortion Care in Mexico and South Africa · NA · terminated
NCT04242212 — Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion · unknown
NCT03539315 — Adaptation and Testing of the Addressing Reproductive Coercion in HEalth Settings (ARCHES) Intervention in Bangladesh · NA · completed
NCT03727308 — Study of Clinic-based Versus Self-use of Medical Abortion Pills · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04181541 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ipas
Last refreshed: 20 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04181541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing